Concepedia

Lise Boussemart

LB

Statistics

Publications

14

Citations

2.3K

H-Index

13

Active since

2002

Affiliations

Inserm(Current)

Institut Gustave Roussy

Centre National de la Recherche Scientifique

Albert Einstein College of Medicine

Université Paris-Sud

Lise Boussemart is an author at Inserm specializing in medicine, oncology, and dermatology.

ORCID

Publications per year

2002–2023

14

Publications

14

Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab

Camille Hua, Lise Boussemart, Christine Mateus et al. · JAMA Dermatology · 2015 · 650 citations

, , +17

BMP-4 is required for hepatic specification of mouse embryonic stem cell–derived definitive endoderm

Valerie Gouon–Evans, Lise Boussemart, Paul Gadue et al. · Nature Biotechnology · 2006 · 436 citations

, , +16

eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies

Lise Boussemart, Hélène Malka-Mahieu, Isabelle Girault et al. · Nature · 2014 · 360 citations

, , +11

L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus

Emmanuel Cormier, Robert J. Durso, Fotini Tsamis et al. · Proceedings of the National Academy of Sciences · 2004 · 210 citations

, , +17

Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients

Lise Boussemart, Émilie Routier, Céu Mateus et al. · Annals of Oncology · 2013 · 205 citations · Full text

, , +11

1–5 of 14